V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007289 | 240004533 | null | null | Palliative (P) | 2014-03-06 | 2014-03-10 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240033089 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007290 | 240010537 | 1.75 | 87.1 | Palliative (P) | 2014-09-27 | 2014-10-26 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 240033090 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007291 | 240010537 | 1.75 | 70 | Curative (C) | 2013-09-09 | 2013-09-10 | INTERLACE TRIAL | N | N | 240033090 | INTERLACE TRIAL |
| 240007292 | 240010537 | 1.67 | 88.2 | null | 2015-10-01 | 2015-10-05 | DA | N | N | 240033090 | DA |
| 240007293 | 240004534 | 1.54 | 49 | Curative (C) | 2016-04-09 | 2016-04-25 | CYTARABINE + DAUNORUBICIN | N | N | 240033098 | DA |
| 240007294 | 240004535 | 0 | 69.3 | Adjuvant (A) | null | 2016-03-15 | Carboplatin + Etoposide iv&po | 2 | N | 240033099 | CARBOPLATIN + ETOPOSIDE |
| 240007295 | 240004535 | 1.75 | 99.5 | Palliative (P) | 2015-06-20 | 2017-03-14 | Hydroxycarbamide | N | N | 240033099 | HYDROXYCARBAMIDE |
| 240007296 | 240004535 | 1.71 | 83.2 | Palliative (P) | null | 2014-02-28 | Chlorambucil | 01 | N | 240033099 | CHLORAMBUCIL |
| 240007297 | 240004536 | 0 | 60.6 | Curative (C) | 2017-04-11 | 2017-04-18 | INTERLACE TRIAL | N | N | 240033104 | INTERLACE TRIAL |
| 240007298 | 240004537 | 1.45 | 63 | Curative (C) | 2013-02-02 | 2013-07-12 | DA 3 + 10 | 02 | N | 240033106 | DA |
| 240007299 | 240004538 | null | 60 | Curative (C) | 2016-06-12 | 2016-06-15 | Chlorambucil | N | N | 240033112 | CHLORAMBUCIL |
| 240007300 | 240004538 | 1.7 | 60 | Adjuvant (A) | 2017-10-16 | 2017-10-22 | null | 02 | null | 240033112 | NOT MATCHED |
| 240007301 | 240004539 | 1.68 | 82.5 | Palliative (P) | 2018-08-03 | 2018-08-03 | Chlorambucil | 02 | N | 240033117 | CHLORAMBUCIL |
| 240007302 | 240004540 | 1.52 | 58.4 | null | 2013-03-15 | 2013-03-20 | CARBOPLATIN + ETOPOSIDE | N | N | 240033119 | CARBOPLATIN + ETOPOSIDE |
| 240007303 | 240004541 | 1.72 | 64 | Disease modification (D) | 2017-07-02 | 2017-07-02 | Chlorambucil | N | N | 240033120 | CHLORAMBUCIL |
| 240007305 | 240004543 | 1.72 | 119.2 | Curative (C) | 2017-10-30 | 2017-11-30 | Chlorambucil | 2 | N | 240033134 | CHLORAMBUCIL |
| 240007306 | 240004544 | 0 | null | Curative (C) | null | 2013-05-30 | R Chlorambucil | N | N | 240033135 | CHLORAMBUCIL + RITUXIMAB |
| 240007307 | 240004544 | 1.7 | 102 | Curative (C) | 2016-03-10 | 2016-03-12 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033135 | CHLORAMBUCIL + RITUXIMAB |
| 240007308 | 240004544 | 1.87 | 87.4 | Curative (C) | 2014-08-30 | 2014-09-03 | DA 3 + 10 | 2 | N | 240033135 | DA |
| 240007309 | 240004544 | 1.61 | null | Curative (C) | 2013-11-06 | 2013-11-11 | HD Lymph Pred EuroNet-PHL-LP1 CVP | null | null | 240033135 | NOT MATCHED |
| 240007310 | 240004545 | 1.54 | 68.1 | Palliative (P) | 2013-02-25 | 2013-03-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | Y | 240033141 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007311 | 240004546 | 1.73 | 45.2 | Palliative (P) | 2017-12-19 | 2017-12-26 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240033150 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007312 | 240010541 | null | null | Disease modification (D) | null | 2016-03-05 | R Chlorambucil | null | null | 240033154 | CHLORAMBUCIL + RITUXIMAB |
| 240007313 | 240004547 | null | 65.3 | Curative (C) | 2016-05-12 | 2016-06-11 | Carboplatin AUC 2 - 5 | N | N | 240033157 | CARBOPLATIN |
| 240007314 | 240010542 | 1.34 | 73.5 | Disease modification (D) | 2015-06-07 | 2015-06-08 | Hydroxycarbamide | N | N | 240033161 | HYDROXYCARBAMIDE |
| 240007315 | 240004548 | 1.66 | 0 | Neo-adjuvant (N) | 2017-09-23 | 2017-10-08 | INTERLACE TRIAL | N | N | 240033165 | INTERLACE TRIAL |
| 240007316 | 240004549 | null | 79.6 | Palliative (P) | 2015-06-06 | 2015-06-06 | DA 3 + 10 | N | N | 240033167 | DA |
| 240007317 | 240004550 | 1.6 | 76 | Palliative (P) | null | 2016-05-26 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240033168 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007318 | 240004551 | 1.55 | null | null | 2015-11-30 | 2015-12-06 | R Chlorambucil | N | null | 240033172 | CHLORAMBUCIL + RITUXIMAB |
| 240007319 | 240010543 | 1.6 | 79.5 | Palliative (P) | 2017-08-05 | 2017-08-31 | Bevacizumab+Carbo+Pacliaxel | N | N | 240033173 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007320 | 240010543 | 1.66 | 96.9 | Disease modification (D) | 2014-09-14 | 2014-09-18 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240033173 | CHLORAMBUCIL + RITUXIMAB |
| 240007321 | 240004552 | 1.52 | 70 | Adjuvant (A) | 2015-04-25 | 2015-05-01 | Carboplatin + Etoposide iv&po | N | N | 240033179 | CARBOPLATIN + ETOPOSIDE |
| 240007322 | 240004553 | 1.69 | 84.4 | Curative (C) | 2017-09-02 | 2017-09-03 | BENDAMUSTINE | 2 | N | 240033188 | BENDAMUSTINE |
| 240007323 | 240004553 | 1.59 | 82.85 | Palliative (P) | null | 2015-12-28 | Chlorambucil | 02 | N | 240033188 | CHLORAMBUCIL |
| 240007324 | 240004554 | null | 58.4 | Palliative (P) | 2014-02-05 | 2014-02-05 | Hydroxycarbamide | N | N | 240033191 | HYDROXYCARBAMIDE |
| 240007325 | 240004555 | 1.81 | 0 | Curative (C) | 2015-08-23 | 2015-09-19 | CARBOPLATIN | N | N | 240033193 | CARBOPLATIN |
| 240007326 | 240004556 | 1.6 | 134 | null | null | 2017-09-03 | LI-1 TRIAL | N | N | 240033195 | TRIAL |
| 240007327 | 240004557 | 1.67 | null | Palliative (P) | 2014-10-06 | 2014-10-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 240033199 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007328 | 240010545 | 1.52 | null | Palliative (P) | 2017-10-29 | 2017-11-03 | Chlorambucil | 02 | N | 240033202 | CHLORAMBUCIL |
| 240007329 | 240010545 | 1.34 | null | null | 2014-05-31 | 2014-06-06 | Bendamustine + prednisolone | N | null | 240033202 | BENDAMUSTINE |
| 240007330 | 240004558 | 1.51 | 55.7 | Palliative (P) | 2016-12-11 | 2016-12-16 | Carboplatin + Etoposide IV 3 day | null | null | 240033214 | CARBOPLATIN + ETOPOSIDE |
| 240007331 | 240004559 | 1.56 | 46.6 | Palliative (P) | 2017-07-02 | 2017-07-04 | Chlorambucil | N | N | 240033224 | CHLORAMBUCIL |
| 240007332 | 240004559 | 1.62 | 59 | Adjuvant (A) | 2013-08-13 | 2013-08-13 | Trial Unspecified | N | N | 240033224 | TRIAL |
| 240007333 | 240004559 | null | null | Not known (9) | 2016-04-09 | 2016-04-22 | R Chlorambucil | null | null | 240033224 | CHLORAMBUCIL + RITUXIMAB |
| 240007334 | 240004560 | 1.75 | 78 | null | 2017-11-06 | 2017-11-12 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240033230 | CHLORAMBUCIL + RITUXIMAB |
| 240007335 | 240004560 | 1.59 | 57 | Disease modification (D) | 2017-07-27 | 2017-07-29 | Chlorambucil | 2 | N | 240033230 | CHLORAMBUCIL |
| 240007336 | 240004561 | 1.72 | 64 | Not known (9) | 2014-09-26 | 2014-09-28 | Bendamustine +/- Prednisolone | N | N | 240033236 | BENDAMUSTINE |
| 240007337 | 240004562 | null | 58.9 | Palliative (P) | 2014-02-27 | 2014-02-27 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 240033237 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007338 | 240010548 | null | 45 | Curative (C) | 2014-12-04 | 2014-12-04 | DA 3 + 10 | 02 | N | 240033241 | DA |
| 240007339 | 240004563 | 1.7 | 88.6 | Adjuvant (A) | 2015-10-16 | 2015-10-19 | R Chlorambucil | 2 | N | 240033243 | CHLORAMBUCIL + RITUXIMAB |